Susceptibilities of ESBL-producing enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid

D Raveh, AM Yinnon, E Broide, B Rudensky - Chemotherapy, 2007 - karger.com
… reported by our laboratory as being sensitive to extended spectrum lactam agents [8] , but
… against ertapenem, meropenem and piperacillin-tazobactam, according to the manufacturer’…

SHV Hyperproduction as a Mechanism for PiperacillinTazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible Klebsiella pneumoniae

MS Han, KS Park, JH Jeon, JK Lee, JH Lee… - Microbial Drug …, 2020 - liebertpub.com
… This study aimed to determine the mechanism of resistance to piperacillintazobactam (TZP)
in Klebsiella pneumoniae bloodstream isolates that are susceptible to extended-spectrum

[HTML][HTML] … -cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-β-lactamase …

MJ Pultz, CJ Donskey - Antimicrobial agents and chemotherapy, 2007 - Am Soc Microbiol
… In comparison to saline controls, piperacillin-tazobactam … In summary, although ceftriaxone
and piperacillin-tazobactam … persistent overgrowth and piperacillin-tazobactam did not …

[HTML][HTML] Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections

CM Perry, A Markham - Drugs, 1999 - Springer
… Because of the broad spectrum of antibacterial activity provided by piperacillin/tazobactam, it
is … polymicrobial infections caused by aerobic or anaerobic β-lactamase-producing bacteria. …

[HTML][HTML] The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella …

J Lee, CE Oh, EH Choi, HJ Lee - International Journal of Infectious …, 2013 - Elsevier
… This study evaluated the impact of the increased use of piperacillin/tazobactam (TZP) on
the … Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-…

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

ME Falagas, GS Tansarli, K Ikawa… - Clinical infectious …, 2013 - academic.oup.com
… OR piperacillin/tazobactam) AND (extended OR prolonged OR continuous OR discontinuous
OR intermittent OR short OR bolus OR intravenous) AND (duration OR infusion OR …

PiperacillinTazobactam: A New βLactamβLactamase Inhibitor Combination

KP Daniel, LC Krop - … The Journal of Human Pharmacology and …, 1996 - Wiley Online Library
Piperacillin-tazobactam is a new p-lactam-plactamase inhibitor combination with a broad
spectrum of activity. Its clinical efficacy and adverse effect profile compare with those of the …

Extended-spectrum β-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options

G Peirano, JDD Pitout - Drugs, 2019 - Springer
… study has provided clear evidence that piperacillin-tazobactam should be avoided for targeted
… species, and susceptibility result of piperacillin-tazobactam. Research is still warranted to …

In vitro activity of β-lactam and non–β-lactam antibiotics in extended-spectrum β-lactamase–producing clinical isolates of Escherichia coli

AS Puerto, JG Fernández, JDL Del Castillo… - … and infectious disease, 2006 - Elsevier
… except for the greater activity of piperacillin/tazobactam, cefoxitin, … These results for
piperacillin/tazobactam, cefoxitin, and … system to detect extended-spectrum beta-lactamases in …

Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance …

PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee… - Jama, 2018 - jamanetwork.com
… , and 78.9% were nonsusceptible to piperacillin-tazobactam. Other microbiological exclusions
… with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. …